Company record
Nana Barseghian, M.D.
1 FDA warning letter since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about Nana Barseghian, M.D..
Warning letters
-
DrugsNana Barseghian, M.D.
FDA warns clinical investigator Nana Barseghian for enrolling high-body-mass-index subjects in drug trials despite protocol exclusion.
High risk